Microbiome science is moving forward.
The market is still taking shape.

Strategy, adoption and growth at the intersection of biology, markets and everyday life.

Questions leaders bring to me.

Which opportunity should we stop pursuing?

Are we selling into a market, or still having to create one?

What would actually make a customer change behaviour and adopt?

What has to stop being bespoke before this can really scale?

What I work on.

Strategy & Reinvention

When the assumptions behind the business no longer hold, decide what to preserve, change or stop.

Growth strategy in emerging markets

Build demand and routes to revenue while customers, buying habits and the market itself are still forming.

Adjacent market development

Find and test new applications for capabilities you already have.

Adoption strategy

Identify the decision, behaviour or workflow that must change for a proposition to be used.

Scaling beyond bespoke

Turn repeated custom work into an offer, delivery model and economics that can grow.

Fundraising strategy & M&A support

Clarify the strategic case for investment or a transaction, and the evidence needed to support it.

How we work together.

The challenge defines the work. The way we work together depends on the decisions ahead and how closely you need me involved.

Focused engagements
Review+

An independent view on a defined opportunity, plan or decision. We agree the scope and fee in advance.

Workshop+

A prepared working session to challenge assumptions and make choices with your team.

Continuing relationships
Advisory+

Confidential, ongoing support as decisions specific to your organisation evolve, including at board level when appropriate.

Embedded adviser+

I join your team in a defined role for a period, helping shape decisions and carry the work forward.

Market-building partnership+

We work over time on a proposition and its route to market, engaging buyers and partners to build demand and make it viable.

Decision membership+

A continuing relationship with curated market signals and regular, private discussion of what they mean for your decisions.

Selected outcomes.

Some outcomes are easy to count. Others change the direction of the business.

€800kContracted revenueSix months as an embedded CBO.
3×Revenue growthRecorded three months after work to narrow the market and sharpen the proposition.
$1M+Funding subsequently securedFollowing work on the proposition and investor story.

Not everything that matters fits in a number.

  • Clearer strategic direction
  • A proposition the market could understand
  • New opportunities beyond the original technology
  • Knowing what not to pursue
  • Bespoke work moving towards something scalable

Selected outcomes reflecting client context and Bridgyz contribution. Client names withheld for confidentiality.

Selected organisations
NahibuCmbioSequential BioInternational Rice Research Institute
Independent and confidential.Potential conflicts are flagged early. Client information stays within the engagement.

Let’s start a conversation.

Contact →

Want to know more first?

View the introduction deck →